![SanBio Company Limited logo](/logos/4592.T.webp)
SanBio Company Limited
TSE:4592.T
Overview | Financials
Company Name | SanBio Company Limited |
Symbol | 4592.T |
Currency | JPY |
Price | 938 |
Market Cap | 64,375,345,216 |
Dividend Yield | 0% |
52-week-range | 380 - 1,489 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Keita Mori MBA |
Website | https://www.sanbio.jp |
An error occurred while fetching data.
About SanBio Company Limited
SanBio Company Limited develops, produces, and sells regenerative cell medicines for the central nervous system. The company develops SB623 that has completed a phase 2 clinical trial to treat traumatic brain injury in the United States and Japan. Its research pipeline products also comprise SB623 for ischemic and hemorrhagic strokes,
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD